drugset / Trial / NCT06708663
HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
NaSingle-groupOpen-labelTreatment
Summary
Phase IIa study of HX009+ IN10018 in combination with or without standard chemotherapy in patients with advanced solid tumours including biliary tract malignancies and malignant melanoma
Timeline
- Start
- 2025-01-17
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HX009 | Protein / enzyme biologic | 7.5 mg/kg | — |
| Subject | HX009 | Protein / enzyme biologic | 10 mg/kg | — |
| Subject | Ifebemtinib | Small molecule | 100 mg | — |